We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+2.73%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$67.2B
AUM Growth
+$540M
(+0.81%)
Cap. Flow
-$425M
Cap. Flow
% of AUM
-0.63%
Top 10 Holdings %
Top 10 Hldgs %
16.83%
Holding
780
New
63
Increased
245
Reduced
379
Closed
79
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$840M |
| 2 |
RTX Corp
RTX
|
+$638M |
| 3 |
Trane Technologies
TT
|
+$326M |
| 4 |
APC
Anadarko Petroleum
APC
|
+$299M |
| 5 |
Gilead Sciences
GILD
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$489M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$397M |
| 3 |
ExxonMobil
XOM
|
+$325M |
| 4 |
Comcast
CMCSA
|
+$322M |
| 5 |
TWX
Time Warner Inc
TWX
|
+$293M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.95% |
| 2 | Healthcare | 16.68% |
| 3 | Technology | 16.63% |
| 4 | Industrials | 11.79% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
JPMorgan Chase
JPM
$942B
| $1.5B | 2.23% |
24,694,020
-1,204,598
| -5% | -$71.3M |
|
2
Wells Fargo
WFC
$257B
| $1.34B | 1.99% |
24,583,186
-3,098,539
| -11% | -$167M |
|
3
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.27B | 1.89% |
8,776,188
-194,178
| -2% | -$28.6M |
|
4
Capital One
COF
$133B
| $1.24B | 1.85% |
15,785,254
-243,371
| -2% | -$19.1M |
|
5
Pfizer
PFE
$160B
| $1.14B | 1.7% |
34,665,429
-4,025,962
| -10% | -$128M |
|
|
6
Citigroup
C
$223B
| $1.04B | 1.54% |
20,105,947
-9,608,686
| -32% | -$489M |
|
7
Apple
AAPL
$4.59T
| $1B | 1.49% |
32,248,316
-462,432
| -1% | -$14M |
|
8
Johnson & Johnson
JNJ
$640B
| $970M | 1.44% |
9,640,931
-702,108
| -7% | -$71.4M |
|
9
Allstate
ALL
$65.1B
| $912M | 1.36% |
12,815,845
+43,763
| +0.3% | +$3.09M |
|
10
Medtronic
MDT
$115B
| $896M | 1.33% |
11,493,847
+3,342,279
| +41% | +$253M |
|
11
CVS Health
CVS
$119B
| $893M | 1.33% |
8,649,516
-558,525
| -6% | -$56.5M |
|
12
Cisco
CSCO
$442B
| $881M | 1.31% |
32,010,491
-1,278,246
| -4% | -$36M |
|
|
13
Merck
MRK
$369B
| $814M | 1.21% |
+14,837,117
| New | +$840M |
|
14
Microsoft
MSFT
$3.75T
| $802M | 1.19% |
19,732,706
+115,477
| +0.6% | +$5.03M |
|
15
Phillips 66
PSX
$95.7B
| $767M | 1.14% |
9,761,720
-93,222
| -0.9% | -$6.84M |
|
|
EMC
16
DELISTED
EMC CORPORATION
EMC
| $764M | 1.14% |
29,885,737
-966,286
| -3% | -$26.6M |
|
|
ESRX
17
DELISTED
Express Scripts Holding Company
ESRX
| $745M | 1.11% |
8,580,771
-316,451
| -4% | -$26.5M |
|
18
Western Digital
WDC
$167B
| $683M | 1.02% |
9,935,913
+951,936
| +11% | +$74.4M |
|
19
Oracle
ORCL
$438B
| $679M | 1.01% |
15,746,620
-1,035,177
| -6% | -$44.9M |
|
|
ATVI
20
DELISTED
Activision Blizzard
ATVI
| $679M | 1.01% |
29,874,466
-162,863
| -0.5% | -$3.57M |
|
|
21
RTX Corp
RTX
$286B
| $670M | 1% |
9,084,876
+8,536,096
| +1,555% | +$638M |
|
22
Liberty Global Class C
LBTYK
$3.51B
| $666M | 0.99% |
16,521,302
+67,476
| +0.4% | +$2.67M |
|
23
Lockheed Martin
LMT
$131B
| $650M | 0.97% |
3,204,973
-109,274
| -3% | -$21.6M |
|
24
Lear
LEA
$8.23B
| $634M | 0.94% |
5,723,609
-555,653
| -9% | -$58.4M |
|
25
TE Connectivity
TEL
$58.8B
| $634M | 0.94% |
8,851,224
-838,073
| -9% | -$57.6M |
|
Similar funds
Boston Partners's Q1 2015 Portfolio in Review
As of Q1 2015, Boston Partners held 780 positions worth $67.2B, up 0.81% from $66.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Partners's Q1 2015 filing shows 63 new, 245 increased, 379 reduced and 79 closed positions. Its largest new stake was Merck: 14,837,117 shares worth $814M. The largest sale was Citigroup, an estimated $489M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Technology.
- Boston Partners's largest Q1 2015 buy was Merck: 14,837,117 shares worth $814M.
- Boston Partners added most to RTX Corp in Q1 2015, an estimated $638M increase.
- Boston Partners's biggest Q1 2015 reduction was Citigroup, cutting an estimated $489M.
- Boston Partners fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $397M.
- Boston Partners's ten largest holdings make up 17% of its $67.2B portfolio in Q1 2015.
- Boston Partners opened 63 new positions and closed 79 in Q1 2015.
- Boston Partners's portfolio value rose 0.81% quarter-over-quarter to $67.2B.
Based on Boston Partners's 13F filing for Q1 2015, filed 5 May 2015.